Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature

BI Goldstein, DE Kemp… - The Journal of …, 2009 - legacy.psychiatrist.com
Objective: To review extant literature implicating inflammation in the pathophysiology of
bipolar disorder. Furthermore, we review evidence regarding the anti-inflammatory actions …

Cytokines in schizophrenia and the effects of antipsychotic drugs

Ł Drzyzga, E Obuchowicz, A Marcinowska… - Brain, behavior, and …, 2006 - Elsevier
Growing evidence suggests that the immune, endocrine, and nervous systems interact with
each other through cytokines, hormones, and neurotransmitters. The activation of the …

Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters

KJ Davey, SM O'Mahony, H Schellekens… - …, 2012 - Springer
Abstract Rationale Atypical antipsychotic drugs (AAPDs) such as olanzapine have a serious
side effect profile including weight gain and metabolic dysfunction, and a number of studies …

Early risk factors for miscarriage: a prospective cohort study in pregnant women

PC Arck, M Rücke, M Rose, J Szekeres-Bartho… - Reproductive …, 2008 - Elsevier
Many pregnancies are lost during early gestation, but clinicians still lack tools to recognize
risk factors for miscarriage. Thus, the identification of risk factors for miscarriage during the …

Neuroprogression in schizophrenia: pathways underpinning clinical staging and therapeutic corollaries

J Davis, S Moylan, BH Harvey… - Australian & New …, 2014 - journals.sagepub.com
Objective: Whilst dopaminergic dysfunction remains a necessary component involved in the
pathogenesis of schizophrenia, our current pharmacological armoury of dopamine …

Hyperleptinemia contributes to antipsychotic drug–associated obesity and metabolic disorders

S Zhao, Q Lin, W Xiong, L Li, L Straub… - Science translational …, 2023 - science.org
Despite their high degree of effectiveness in the management of psychiatric conditions,
exposure to antipsychotic drugs, including olanzapine and risperidone, is frequently …

Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents

VL Albaugh, CR Henry, NT Bello, A Hajnal, SL Lynch… - …, 2006 - Wiley Online Library
Objective: To characterize a model of atypical antipsychotic drug‐induced obesity and
evaluate its mechanism. Research Methods and Procedures: Chronically, olanzapine or …

A systematic review of clozapine‐associated inflammation and related monitoring

JG Leung, L Zhang, M Markota… - … : The Journal of …, 2023 - Wiley Online Library
Clozapine is an effective antipsychotic medication used for treatment‐resistant
schizophrenia. However, it is underutilized due to rigorous hematologic monitoring …

Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin

H Jin, JM Meyer, S Mudaliar, DV Jeste - Schizophrenia research, 2008 - Elsevier
BACKGROUND: Many adverse effects of atypical antipsychotic treatment are associated
with antagonism of monoamine receptors; however, data indicate that important metabolic …

Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo …

T Baptista, N Rangel, V Fernández, E Carrizo… - Schizophrenia …, 2007 - Elsevier
BACKGROUND: Excessive body weight gain (BWG) is a clinically relevant side effect of
olanzapine administration. The primary objective of this study was to assess whether …